Tumor Marker Test Uncut Sheet
NewScen offers a wide range of Tumor Marker lateral flow rapid test kits to detect various infections like PSA, AFP, CEA, FOB, and TF. Our test kits ensure fast and accurate results.
We provide uncut sheets for all our products, allowing for easy customization and scalability based on your needs. With NewScen, you can trust in our reliable and efficient tumor marker testing solutions. We are dedicated to delivering the highest quality products to meet your testing requirements.
List of Other Available Tumor Marker Test Uncut Sheet
NewScen provides rapid diagnostic test uncut sheets for all our produced lateral flow assays. If the specific uncut sheet you require is not listed, please don’t hesitate to contact us for more details.
Understanding Our Target Audience
Please feel free to contact us immediately to request samples for your Uncut Sheet business before commencing the rapid test production.
FAQ
Tumor marker tests are used to detect certain substances in the body that may be indicative of the presence of a tumor or the progression of cancer. There are various types of tumor marker tests available, and the choice of test depends on the specific type of cancer being evaluated. Here are some common types of tumor marker tests:
Prostate-Specific Antigen (PSA) Test: This test measures the levels of PSA, a protein produced by the prostate gland. Elevated levels of PSA may indicate the presence of prostate cancer or other prostate conditions.
Carcinoembryonic Antigen (CEA) Test: CEA is a protein found in some types of cancer, particularly colorectal cancer. This test measures the levels of CEA in the blood to monitor the response to treatment or detect the recurrence of cancer.
CA-125 Test: This test measures the levels of CA-125, a protein that may be elevated in ovarian cancer. It is commonly used to monitor the response to treatment and detect the recurrence of ovarian cancer.
Alpha-fetoprotein (AFP) Test: AFP is a protein produced by the liver and yolk sac of a developing fetus. Elevated levels of AFP in adults may be associated with liver cancer or certain germ cell tumors.
Human Chorionic Gonadotropin (hCG) Test: hCG is a hormone produced during pregnancy. In non-pregnant individuals, elevated levels of hCG may indicate the presence of certain cancers, such as testicular or gestational trophoblastic tumors.
CA 19-9 Test: This test measures the levels of CA 19-9, a protein that may be elevated in pancreatic, colorectal, and other gastrointestinal cancers. It is primarily used to monitor the response to treatment and detect the recurrence of these cancers.
HER2/neu Test: This test evaluates the levels of human epidermal growth factor receptor 2 (HER2/neu) protein in breast cancer cells. It helps determine the treatment approach for breast cancer, as some therapies specifically target HER2-positive tumors.
It's important to note that tumor marker tests are not definitive diagnostic tools for cancer. They are used in conjunction with other diagnostic methods, such as imaging tests and biopsies, to aid in the diagnosis, staging, and monitoring of cancer. Interpretation of tumor marker test results should be done by qualified healthcare professionals.
No, AFP (Alpha-fetoprotein) is not a tumor marker in the sense that it is not specific to tumors. AFP is a protein that is normally produced by the liver and the yolk sac of a developing fetus. In adults, elevated levels of AFP can be seen in certain conditions, including liver diseases, such as hepatitis and cirrhosis, as well as during pregnancy.
However, AFP can be used as a tumor marker in specific cases. It is primarily associated with certain types of liver cancer, particularly hepatocellular carcinoma (HCC). Elevated levels of AFP in the blood can indicate the presence of HCC, but it is important to note that not all individuals with HCC will have elevated AFP levels, and elevated AFP levels can also be seen in other noncancerous conditions. Therefore, AFP is not a definitive tumor marker for all types of cancers, but it can be a useful tool in combination with other diagnostic tests and clinical evaluation for the detection and monitoring of liver cancer.
The AFP (Alpha-fetoprotein) test is a blood test that measures the levels of AFP, a protein produced by the liver and the yolk sac of a developing fetus. It is commonly used as a screening tool during pregnancy to detect certain birth defects and abnormalities, as well as to monitor liver diseases and certain types of cancer.
The normal range for AFP can vary depending on the specific laboratory and testing methods used. However, as of my knowledge cutoff in September 2021, the general reference range for AFP in non-pregnant adults is typically less than 10 nanograms per milliliter (ng/mL). It's important to note that the normal range can differ for pregnant women at different stages of pregnancy.
However, reference ranges may vary from one laboratory to another, so it is always best to consult with a healthcare professional who can interpret the test results in the context of an individual's specific situation. They will be able to provide you with the most accurate and up-to-date information regarding AFP test results and their implications.
The rapid test for fecal occult blood (FOB) is a diagnostic tool used to detect the presence of hidden or microscopic blood in the stool. FOB tests are commonly used to screen for colorectal cancer and other gastrointestinal disorders. The rapid test involves the use of specialized kits that contain reagents designed to react with blood components, such as hemoglobin. These kits typically employ immunochemical methods, such as immunochromatographic or immunoturbidimetric assays, to detect the presence of blood.
During the test, a small sample of stool is collected by the patient and applied to the test strip or device. The test strip contains antibodies or other molecules that can specifically bind to the blood components present in the sample. If blood is present in the stool, the test will produce a visible signal, such as a color change or a line appearing on the strip, indicating a positive result. The entire process usually takes only a few minutes, allowing for rapid and convenient screening.
It is important to note that while the rapid FOB test can indicate the presence of blood in the stool, it cannot determine the exact source or cause of the bleeding. Further diagnostic tests, such as colonoscopy or sigmoidoscopy, are typically recommended to identify the underlying condition.
Yes, lateral flow and rapid flow tests are essentially the same thing. Lateral flow tests, also known as lateral flow immunoassays, are a type of diagnostic test designed to detect the presence of specific substances, such as antigens or antibodies, in a sample. They are commonly used for rapid and on-site testing because of their simplicity and quick results.
The test works by applying the sample (e.g., blood, urine, or saliva) to a test strip containing a series of embedded reagents. The sample flows along the strip, and if the target substance is present, it will bind to the reagents and generate a visual signal, usually in the form of a colored line.
The term "rapid flow test" is often used interchangeably with lateral flow test, emphasizing the quick turnaround time of the test results. These tests have gained significant attention during the COVID-19 pandemic, where they have been widely used for rapid screening and diagnosing of SARS-CoV-2 infections.
In summary, both lateral flow and rapid flow tests refer to the same type of diagnostic test that provides quick results by detecting specific substances in a sample using a flow-based mechanism.